APA

Geskey J. M., Ceneviva G. D., Brummel G. L., Graff G. R. & Javier M. (20050428). Administration of the first dose of palivizumab immunoprophylaxis against respiratory syncytial virus in infants before hospital discharge: what is the evidence for its benefit?. : Clinical therapeutics.

Chicago

Geskey Joseph M, Ceneviva Gary D, Brummel Gretchen L, Graff Gavin R and Javier Maria-Cristina. 20050428. Administration of the first dose of palivizumab immunoprophylaxis against respiratory syncytial virus in infants before hospital discharge: what is the evidence for its benefit?. : Clinical therapeutics.

Harvard

Geskey J. M., Ceneviva G. D., Brummel G. L., Graff G. R. and Javier M. (20050428). Administration of the first dose of palivizumab immunoprophylaxis against respiratory syncytial virus in infants before hospital discharge: what is the evidence for its benefit?. : Clinical therapeutics.

MLA

Geskey Joseph M, Ceneviva Gary D, Brummel Gretchen L, Graff Gavin R and Javier Maria-Cristina. Administration of the first dose of palivizumab immunoprophylaxis against respiratory syncytial virus in infants before hospital discharge: what is the evidence for its benefit?. : Clinical therapeutics. 20050428.